Perspectives and Potential Applications of Ruthenium-Based Nanocarriers for Cancer Therapy

  • Santamaria R
  • Irace C
  • D'Errico G
  • et al.
N/ACitations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Free radicals and reactive oxygen species (ROS) have been associated with the etiology and/or progression of a number of diseases and in aging. Many of the proteins oxidatively modified by free radicals contain side-chain carbonyl derivatives, which can be used as markers for protein oxidation. The protein carbonyl content has been quantitated as a function of age for human cultured dermal fibroblasts, lens, and brain tissue. These data were analyzed using a simple autocatalytic model with the assumption that free radicals randomly oxidize proteins or peptides to form carbonyl derivatives and lead to their inactivation. The carbonylated proteins and peptides are highly susceptible to proteolytic degradation. Implication of free radicals in aging and in age-dependent susceptibility to neurodegenerative diseases will be discussed in light of this simplified kinetic model.

Cite

CITATION STYLE

APA

Santamaria, R., Irace, C., D’Errico, G., Montesarchio, D., & Paduano, L. (2014). Perspectives and Potential Applications of Ruthenium-Based Nanocarriers for Cancer Therapy. Journal of Pharmaceutics and Drug Development, 1(2). https://doi.org/10.15744/2348-9782.1.e201

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free